Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

INTRODUCTION: This study helps to define the implications of breast cancer anti-estrogen resistance 3 (BCAR3) in breast cancer and extends the current understanding of its molecular mechanism of action. BCAR3 has been shown to promote cell proliferation, migration and attachment to extracellular mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jimin, Canaff, Lucie, Rajadurai, Charles Vincent, Fils-Aimé, Nadège, Tian, Jun, Dai, Meiou, Korah, Juliana, Villatoro, Manuel, Park, Morag, Ali, Suhad, Lebrun, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311507/
https://www.ncbi.nlm.nih.gov/pubmed/25499443
http://dx.doi.org/10.1186/s13058-014-0476-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311507/
https://www.ncbi.nlm.nih.gov/pubmed/25499443
http://dx.doi.org/10.1186/s13058-014-0476-9

Ejemplares similares